Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
JAMA
    September 2017
  1. GIULIANO AE, Ballman KV, McCall L, Beitsch PD, et al
    Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    JAMA. 2017;318:918-926.
    >> Share

  2. LIVINGSTON EH, Li HC
    Breast Cancer Surgery: Less Is More.
    JAMA. 2017;318:909-911.
    >> Share

    August 2017
  3. SLOMSKI A
    Olaparib Increased Survival in Metastatic Breast Cancer.
    JAMA. 2017;318:690.
    >> Share

    June 2017
  4. KUCHENBAECKER KB, Hopper JL, Barnes DR, Phillips KA, et al
    Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
    JAMA. 2017;317:2402-2416.
    >> Share

    April 2017
  5. HIMELSTEIN AL, Loprinzi CL, Shapiro CL
    Zoledronic Acid Dosing Interval for Metastatic Cancer-Reply.
    JAMA. 2017;317:1478.
    >> Share

    February 2017
  6. SACKEIM MG
    Eradicating a Genetic Mutation.
    JAMA. 2017;317:809.
    >> Share

  7. ALLEN D
    Moving the Needle on Recovery From Breast Cancer: The Healing Role of Postmastectomy Tattoos.
    JAMA. 2017;317:672-674.
    >> Share

  8. RUGO HS, Klein P, Melin SA, Hurvitz SA, et al
    Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    JAMA. 2017;317:606-614.
    >> Share

  9. NANGIA J, Wang T, Osborne C, Niravath P, et al
    Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    JAMA. 2017;317:596-605.
    >> Share

  10. HERSHMAN DL
    Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come.
    JAMA. 2017;317:587-588.
    >> Share

  11. MUTH CC
    Chemotherapy and Hair Loss.
    JAMA. 2017;317:656.
    >> Share

  12. KURIAN AW, Griffith KA, Hamilton AS, Ward KC, et al
    Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
    JAMA. 2017;317:531-534.
    >> Share

    January 2017
  13. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    >> Share

  14. HIMELSTEIN AL, Foster JC, Khatcheressian JL, Roberts JD, et al
    Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
    JAMA. 2017;317:48-58.
    >> Share

    December 2016
  15. BURSTEIN HJ, Schrag D
    Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18979.
    >> Share

  16. RUGO HS, Barve A, Waller CF, Hernandez-Bronchud M, et al
    Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18305.
    >> Share

    November 2016
  17. ABBASI J
    The Nurses' Health Study Takes Fresh Aim at Breast Cancer as It Heads Into Decade Five.
    JAMA. 2016 Nov 23. doi: 10.1001/jama.2016.15976.
    >> Share

  18. FOUKAKIS T, von Minckwitz G, Bengtsson NO, Brandberg Y, et al
    Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016;316:1888-1896.
    >> Share

    October 2016
  19. SLOMSKI A
    Tumor Gene Testing May Help Guide Breast Cancer Treatment Decisions.
    JAMA. 2016;316:1637.
    >> Share

  20. VAN DEN BELT-DUSEBOUT AW, van Leeuwen FE, Burger CW
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization-Reply.
    JAMA. 2016;316:1713-1714.
    >> Share

  21. TOMAO F, Papa A, Tomao S
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization.
    JAMA. 2016;316:1713.
    >> Share

    July 2016
  22. VAN DEN BELT-DUSEBOUT AW, Spaan M, Lambalk CB, Kortman M, et al
    Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
    JAMA. 2016;316:300-12.
    >> Share

    May 2016
  23. CORLEY DA, Haas JS, Kobrin S
    Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.
    JAMA. 2016;315:2067-8.
    >> Share

  24. TAYLOR-PHILLIPS S, Wallis MG, Jenkinson D, Adekanmbi V, et al
    Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of Breast Cancer Detection: A Randomized Clinical Trial.
    JAMA. 2016;315:1956-65.
    >> Share

  25. BURNSIDE ES, Sickles EA, Duffy SW
    A Pragmatic Approach to Determine Components of Optimal Screening Mammography Practice.
    JAMA. 2016;315:1951-3.
    >> Share

    April 2016
  26. KRESSIN NR, Gunn CM, Battaglia TA
    Content, Readability, and Understandability of Dense Breast Notifications by State.
    JAMA. 2016;315:1786-8.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016